DD 15
Alternative Names: DD-15Latest Information Update: 11 Mar 2024
At a glance
- Originator D and D Pharmatech
- Class Obesity therapies; Peptides
- Mechanism of Action Gastric inhibitory polypeptide receptor agonists; Glucagon receptor agonists; Glucagon-like peptide-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Obesity
Most Recent Events
- 18 Jan 2024 Early research in Obesity in South Korea (PO) (D and D Pharmatech pipeline, January 2024)